Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q9HAV4
UPID:
XPO5_HUMAN
Alternative names:
Ran-binding protein 21
Alternative UPACC:
Q9HAV4; Q5JTE6; Q96G48; Q96HN3; Q9BWM6; Q9BZV5; Q9H9M4; Q9NT89; Q9NW39; Q9ULC9
Background:
Exportin-5, also known as Ran-binding protein 21, plays a crucial role in the nuclear export of proteins and RNAs, including micro-RNA precursors and dsRNA bearing proteins. It operates through a complex interaction with the GTPase Ran, facilitating the transport of cargo across the nuclear pore complex. Its ability to recognize and bind dsRNAs in a sequence-independent manner underscores its significance in cellular processes.
Therapeutic significance:
Understanding the role of Exportin-5 could open doors to potential therapeutic strategies. Its involvement in RNA-mediated gene silencing and the nuclear export of micro-RNA precursors highlights its potential as a target in regulating gene expression and RNA interference pathways.